ELI LILLY & Co is 836.7x more valuable than MoonLake Immunotherapeutics by market capitalization ($1.093 T vs $1.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MLTX | LLY |
|---|---|---|
| Market cap | $1.31 B | $1.093 T |
| US-listed rank | #2448 | #11 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$227.32M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 296 | 989 |
ELI LILLY & Co is 836.7x more valuable than MoonLake Immunotherapeutics by market capitalization ($1.093 T vs $1.31 B).
Full pages: MoonLake Immunotherapeutics and ELI LILLY & Co, or browse the full rankings.